199 related articles for article (PubMed ID: 24518266)
1. Managing tuberous sclerosis in the Asia-Pacific region: refining practice and the role of targeted therapy.
Lawson JA; Chan CF; Chi CS; Fan PC; Kim HD; Kim KJ; Likasitwatanakul S; Ortiz M; Riney K; Tay SK; Tham CK
J Clin Neurosci; 2014 Jul; 21(7):1180-7. PubMed ID: 24518266
[TBL] [Abstract][Full Text] [Related]
2. TOSCA - first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex.
Kingswood JC; Bruzzi P; Curatolo P; de Vries PJ; Fladrowski C; Hertzberg C; Jansen AC; Jozwiak S; Nabbout R; Sauter M; Touraine R; O'Callaghan F; Zonnenberg B; Crippa S; Comis S; d'Augères GB; Belousova E; Carter T; Cottin V; Dahlin M; Ferreira JC; Macaya A; Benedik MP; Sander V; Youroukos S; Castellana R; Ulker B; Feucht M
Orphanet J Rare Dis; 2014 Nov; 9():182. PubMed ID: 25424195
[TBL] [Abstract][Full Text] [Related]
3. Advances in the treatment of tuberous sclerosis complex.
Leclezio L; de Vries PJ
Curr Opin Psychiatry; 2015 Mar; 28(2):113-20. PubMed ID: 25602245
[TBL] [Abstract][Full Text] [Related]
4. [Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].
Waltereit R; Feucht M; de Vries MC; Huemer J; Roessner V; de Vries PJ
Z Kinder Jugendpsychiatr Psychother; 2019 Mar; 47(2):139-153. PubMed ID: 30080117
[TBL] [Abstract][Full Text] [Related]
5. Neurological and neuropsychiatric aspects of tuberous sclerosis complex.
Curatolo P; Moavero R; de Vries PJ
Lancet Neurol; 2015 Jul; 14(7):733-45. PubMed ID: 26067126
[TBL] [Abstract][Full Text] [Related]
6. Description of a multidisciplinary model of care in a French cohort of adult patients with tuberous sclerosis complex.
Pfirmann P; Aupy J; Jambon E; Idier L; Prezelin-Reydit M; Fermis M; Devillard R; Grenier N; Combe C; Rigothier C
J Med Genet; 2021 Jan; 58(1):25-31. PubMed ID: 32409510
[TBL] [Abstract][Full Text] [Related]
7. mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders.
Franz DN; Capal JK
Orphanet J Rare Dis; 2017 Mar; 12(1):51. PubMed ID: 28288694
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous manifestations of tuberous sclerosis complex and the paediatrician's role.
Cardis MA; DeKlotz CMC
Arch Dis Child; 2017 Sep; 102(9):858-863. PubMed ID: 28351834
[TBL] [Abstract][Full Text] [Related]
9. Tuberous sclerosis complex: the past and the future.
De Waele L; Lagae L; Mekahli D
Pediatr Nephrol; 2015 Oct; 30(10):1771-80. PubMed ID: 25533384
[TBL] [Abstract][Full Text] [Related]
10. Experience of follow-up, quality of life, and transition from pediatric to adult healthcare of patients with tuberous sclerosis complex.
Bar C; Ghobeira R; Azzi R; Ville D; Riquet A; Touraine R; Chemaly N; Nabbout R
Epilepsy Behav; 2019 Jul; 96():23-27. PubMed ID: 31077938
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of tuberous sclerosis complex in the UK: A retrospective cohort study in the Clinical Practice Research Datalink.
Kingswood JC; Crawford P; Johnson SR; Sampson JR; Shepherd C; Demuth D; Erhard C; Nasuti P; Patel K; Myland M; Pinnegar A; Magestro M; Gray E
J Med Econ; 2016 Nov; 19(11):1087-1098. PubMed ID: 27267148
[TBL] [Abstract][Full Text] [Related]
12. Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management.
Samueli S; Abraham K; Dressler A; Groeppel G; Jonak C; Muehlebner A; Prayer D; Reitner A; Feucht M;
Wien Klin Wochenschr; 2015 Aug; 127(15-16):619-30. PubMed ID: 25860851
[TBL] [Abstract][Full Text] [Related]
13. Renal tumors in tuberous sclerosis complex.
Trnka P; Kennedy SE
Pediatr Nephrol; 2021 Jun; 36(6):1427-1438. PubMed ID: 33006051
[TBL] [Abstract][Full Text] [Related]
14. Tuberous sclerosis complex: new insights into clinical and therapeutic approach.
Volpi A; Sala G; Lesma E; Labriola F; Righetti M; Alfano RM; Cozzolino M
J Nephrol; 2019 Jun; 32(3):355-363. PubMed ID: 30406604
[TBL] [Abstract][Full Text] [Related]
15. Possible prevention of tuberous sclerosis complex lesions.
Kotulska K; Borkowska J; Jozwiak S
Pediatrics; 2013 Jul; 132(1):e239-42. PubMed ID: 23733802
[TBL] [Abstract][Full Text] [Related]
16. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.
Jóźwiak S; Nabbout R; Curatolo P;
Eur J Paediatr Neurol; 2013 Jul; 17(4):348-52. PubMed ID: 23391693
[TBL] [Abstract][Full Text] [Related]
17. Primary care management of tuberous sclerosis complex in children.
Manohara D
J Am Acad Nurse Pract; 2012 Jul; 24(7):391-9. PubMed ID: 22735062
[TBL] [Abstract][Full Text] [Related]
18. Shared decision-making and the caregiver experience in tuberous sclerosis complex: results from a UK survey.
Skrobanski H; Vyas K; Bowditch S; Hubig L; Dziadulewicz E; Fish L; Takhar P; Lo SH
Orphanet J Rare Dis; 2023 Apr; 18(1):78. PubMed ID: 37041611
[TBL] [Abstract][Full Text] [Related]
19. Effect of Angiofibromas on Quality of Life and Access to Care in Tuberous Sclerosis Patients and Their Caregivers.
Crall C; Valle M; Kapur K; Dies KA; Liang MG; Sahin M; Huang JT
Pediatr Dermatol; 2016 Sep; 33(5):518-25. PubMed ID: 27436143
[TBL] [Abstract][Full Text] [Related]
20. 'We've made the best of it. But we do not have a normal life': families' experiences of tuberous sclerosis complex and seizure management.
McDonald A; Goodwin J; Roberts S; Fish L; Vaughan B; Cooper A; Cadwgan J
J Intellect Disabil Res; 2019 Aug; 63(8):947-956. PubMed ID: 30775832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
